what is known about trial:nct:NCT07784374

A Phase II Study of GFH375 Combined With GFS202A or GFH276 Versus GFH375 in Patients With Previously Treated Locally Advanced Unresectable or Metastatic Pancreatic Cancer Harboring KRAS G12D Mutation NCT07784374↗ Outcome: Ongoing

Computed from the knowledge API (getStudy); every record links to its source.